Sweroside

CAS : 14215-86-2

Ref. 3D-FS73846

Informations sur le produit

• Nom: Sweroside
• Synonymes: (4aS,5R,6S)-5-Ethenyl-6-(β-<span class="text-smallcaps">D</span>-glucopyranosyloxy)-4,4a,5,6-tetrahydro-1H,3H-pyrano[3,4-c]pyran-1-one, (4aS,5R,6S)-5-Ethenyl-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,4a,5,6-tetrahydro-3H-pyrano[3,4-c]pyran-1-one, (4aS,5R,6S)-5-ethenyl-1-oxo-4,4a,5,6-tetrahydro-1H,3H-pyrano[3,4-c]pyran-6-yl beta-D-glucopyranoside, 1H,3H-Pyrano[3,4-c]pyran-1-one, 5-ethenyl-6-(β-<span class="text-smallcaps">D</span>-glucopyranosyloxy)-4,4a,5,6-tetrahydro-, (4aS,5R,6S)-, 1H,3H-Pyrano[3,4-c]pyran-1-one, 5-ethenyl-6-(β-<span class="text-smallcaps">D</span>-glucopyranosyloxy)-4,4a,5,6-tetrahydro-, [4aS-(4aα,5β,6α)]-

Description

Sweroside is a natural compound that belongs to the family of bioactive phenolic compounds. It has been shown to have anti-inflammatory and genotoxic activities. Sweroside also inhibits the production of serotonin in the brain and thereby prevents the onset of ischemia-reperfusion injury. In addition, sweroside has been found to be effective in treating myocardial infarct in rats and inhibiting 5-HT2 receptors. Sweroside can be detected using an analytical method involving HPLC with preparative hplc, human serum, or human osteosarcoma cells as a receptor. The active form of sweroside is loganic acid, which can be isolated from the fructus of Swerria erythrocarpa var. pendula (L.) Seem.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 358.34 g/mol
• Formule: C₁₆H₂₂O₉
• Degré de pureté: Min. 98 Area-%
• Couleur/Forme: Powder